CIMG ( (IMG) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CIMG Inc. has filed a Form 12b-25 to notify investors of a delay in submitting its Form 10-Q (Quarter Report) for the quarter ended December 31, 2025. The company says its internal accounting team needs more time to complete the quarterly financial statements, indicating the delay is driven by preparation workload rather than an auditor dispute or regulatory investigation.
The company expects to file the delayed Form 10-Q (Quarter Report) within the standard SEC grace period, which is up to five calendar days after the original due date for a quarterly filing. Management also notes it intends to submit the report as soon as practicable, signaling that the delay should be short and operational in nature.
CIMG warns that its upcoming results will show a significant change in operations compared with the same period a year earlier. The company has added new revenue streams from homology of medicine and food products and a computing power series, while continuing to sell its Maca series, and it anticipates that these moves have driven a meaningful increase in revenue for the three months ended December 31, 2025.
In addition, CIMG reports that it acquired bitcoins during the quarter, whereas it held none at the end of 2024. As a result, the company expects total assets on its balance sheet to have grown significantly versus the prior year, but it has not yet provided detailed quantitative figures, and all such expectations should be treated as forward-looking statements subject to change when the final Form 10-Q (Quarter Report) is filed.
The notification confirms that CIMG has kept current with all other required SEC filings over the past 12 months, underscoring its intent to remain compliant. The Form 12b-25 is signed by Chief Executive Officer Jianshuang Wang on February 18, 2026, reinforcing that the delay and planned catch-up filing are being managed at the top executive level.
The most recent analyst rating on (IMG) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on CIMG stock, see the IMG Stock Forecast page.
Spark’s Take on IMG Stock
According to Spark, TipRanks’ AI Analyst, IMG is a Underperform.
CIMG’s overall stock score is low due to significant financial challenges and poor valuation metrics. The technical analysis indicates a bearish trend, further impacting the score. While there are some positive corporate developments, they are not enough to offset the financial and compliance issues.
To see Spark’s full report on IMG stock, click here.
More about CIMG
CIMG Inc., formerly known as Nuzee, Inc., is headquartered in Tuen Mun, Hong Kong. The company sells consumer products including a Maca product line and has recently expanded into homology of medicine and food products, as well as computing power-related offerings. It has also begun holding bitcoins as part of its asset base.
Average Trading Volume: 1,232,612
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.52M
For an in-depth examination of IMG stock, go to TipRanks’ Overview page.